Related by context. Frequent words. (Click for all words.) 68 Advanced Prostate Cancer 67 Prostate Cancer Patients 67 Improves Survival 66 Meets Primary Endpoint 66 Epilepsy Drug 66 Cholesterol Drugs 65 Clinical Trial Results 65 Renal Cell Carcinoma 65 Cognitive Impairment 65 By MICHAEL RADANO 64 Heart Failure Patients 64 Significantly Improved 64 Preclinical Data 64 Postmenopausal Women 64 Venous Thromboembolism 63 Drug Shows Promise 63 Study Evaluating 63 Elderly Patients 63 Survival Rates 63 Phase III Trial 63 Cognitive Function 63 Pediatric Patients 63 Stronger Than Expected 63 YOUR LOCAL ANIMAL SHELTER 63 Chronic Hepatitis C 63 Well Tolerated 62 Patient Outcomes 62 FY# Guidance 62 Primary Endpoint 62 Surgical Procedures 62 Meta Analysis 62 Genetic Tests 62 Drug Candidate 62 Milestone Payment 62 Mouse Model 62 Patients Undergoing 61 Cholesterol Levels 61 Lung Cancer Patients 61 Radiation Exposure 61 Single Dose 61 By BRENDAN KIRBY 61 Monotherapy 60 Jobless Claims Fall 60 Smallpox Vaccine 60 Gestational Diabetes 60 Metastatic Melanoma 60 Gastric Cancer 60 Presents Positive 60 Golimumab 60 Jobless Claims Drop 60 Backs FY# EPS 59 Positive Cash Flow 59 Significantly Improves 59 DTN Cattle Prices 59 Guidance Quick Facts 59 Gender Differences 59 Overactive Bladder 59 Antihypertensive 59 Metastatic Colorectal Cancer 59 Preliminary Second Quarter 59 Breast Cancer Treatment 59 Completes Enrollment 59 Fast Track Status 59 • Hitlists • 59 receiving VELCADE 59 Adverse Effects 59 Pharmacokinetic 59 Medication Adherence 59 CME Livestock Review 59 Patients Treated 59 Pharmacodynamic 58 Guides FY# 58 Raises FY# EPS 58 FDA Clears 58 Record Second Quarter 58 comScore Releases 58 Revenues Decline 58 Controlled Trial 58 Reaffirms Guidance 58 Significant Increase 58 * SPOILERS * 58 2nd Quarter Results 58 Myelodysplastic Syndromes 58 Weaker Than Expected 58 Cuts FY# EPS 58 Pivotal Phase III 58 Help Predict 58 Comp Store 58 Radiofrequency Ablation 57 Racial Disparities 57 Jobless Claims Rise 57 Gap Narrows 57 Pivotal Study 57 Angiographic 57 By Sandra Grauschopf 57 FDA Accepts 57 Receives Orphan Drug Designation 57 Updates Guidance 57 Preliminary Third Quarter 57 Robust Growth 57 Economic Optimism